LABSTANDARD BIOTOOLS INC.

Nasdaq fluidigm.com


$ 2.56 $ 0.07 (2.8 %)    

Friday, 17-May-2024 15:59:56 EDT
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 2.57
$ 2.53
$ 2.56 x 2,752
$ 2.57 x 3,900
$ 2.48 - $ 2.59
$ 1.57 - $ 3.16
2,935,437
na
203.44M
$ 2.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-01-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-14-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-08-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-07-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 03-18-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 03-08-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 03-03-2017 12-31-2016 10-K
31 11-09-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
37 05-11-2015 03-31-2015 10-Q
38 02-26-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-04-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 standard-biotools-reaffirms-fy24-revenue-guidance-of-200m-205m

  Outlook for 2024 For fiscal year 2024, the Company reaffirmed full year revenue guidance, which is expected to be in the ra...

 standard-biotools-q1-2024-gaap-eps-027-misses-012-estimate-sales-45540m-miss-46006m-estimate

Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(...

 standard-biotools-plans-operational-restructuring--implements-reduction-of-approximately-10-of-its-total-workforce

The restructuring plan is expected to generate annualized operating expense savings of $45 million to $50 million in fiscal 202...

 td-cowen-initiates-coverage-on-standard-biotools-with-buy-rating-announces-price-target-of-35

TD Cowen analyst Daniel Brennan initiates coverage on Standard BioTools (NASDAQ:LAB) with a Buy rating and announces Price T...

 jefferies-initiates-coverage-on-standard-biotools-with-buy-rating-announces-price-target-of-325

Jefferies analyst Matthew Stanton initiates coverage on Standard BioTools (NASDAQ:LAB) with a Buy rating and announces Price...

Core News & Articles

Standard BioTools Inc. (NASDAQ:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ –...

 standard-biotools-announces-exchange-of-all-outstanding-series-b-convertible-preferred-stock-for-common-stock-pursuant-to-an-agreement-with-stockholders-affiliated-with-viking-global-investors-and-casdin-capital

Standard BioTools Inc. ("Standard BioTools" or the "Company") (NASDAQ:LAB) today announced that it has exchange...

 quantum-si-and-2-other-penny-stocks-insiders-are-buying

The Dow Jones index closed higher by around 75 points on Wednesday. When insiders purchase or sell shares, it indicates their c...

 standard-biotools-expects-combined-company-revenue-of-200m-205m-est-1202m

The company's merger with SomaLogic closed on January 5, 2024.

 standard-biotools-q4-2023-gaap-eps-025-misses-024-estimate-sales-2819m-beat-2490m-estimate

Standard BioTools (NASDAQ:LAB) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(...

 earnings-scheduled-for-february-28-2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

 standard-biotools-and-next-gen-diagnostics-announce-partnership-to-provide-complete-automation-of-low-cost-pathogen-sequencing

 Standard BioTools Inc. (NASDAQ:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ ...

 standard-biotools-and-navignostics-announce-collaboration-agreement-to-advance-imaging-capabilities-in-personalized-medicine

Standard BioTools Inc. (NASDAQ:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ –...

 standard-biotools-announces-full-year-2023-revenue-of-106m-somalogic-expects-q4-2023-revenue-of-23m-and-fy23-revenue-of-86m

Standard BioTools Inc. (NASDAQ:LAB) (Standard BioTools or the Company), driven by a bold purpose – Unleashing tools to accelera...

Core News & Articles

Highlights Current Merger Consideration, Which Assigns No Value and No Premium to SomaLogic's Desirable Assets, Represents ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION